These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]
45. Valve Type, Size, and Deployment Location Affect Hemodynamics in an In Vitro Valve-in-Valve Model. Midha PA; Raghav V; Condado JF; Okafor IU; Lerakis S; Thourani VH; Babaliaros V; Yoganathan AP JACC Cardiovasc Interv; 2016 Aug; 9(15):1618-28. PubMed ID: 27491613 [TBL] [Abstract][Full Text] [Related]
47. Overexpansion of the 29 mm SAPIEN 3 transcatheter heart valve in patients with large aortic annuli (area > 683 mm Mathur M; McCabe JM; Aldea G; Pal J; Don CW Catheter Cardiovasc Interv; 2018 May; 91(6):1149-1156. PubMed ID: 28836337 [TBL] [Abstract][Full Text] [Related]
48. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction. Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280 [TBL] [Abstract][Full Text] [Related]
49. In vitro hemodynamic assessment of a novel polymeric transcatheter aortic valve. Heitkemper M; Hatoum H; Dasi LP J Mech Behav Biomed Mater; 2019 Oct; 98():163-171. PubMed ID: 31238208 [TBL] [Abstract][Full Text] [Related]
50. Early Clinical Outcomes of Transcatheter Aortic Valve Replacement in Left Ventricular Outflow Tract Calcification: New-Generation Device vs Early-Generation Device. Nomura T; Maeno Y; Yoon SH; Abramowitz Y; Israr S; Miyasaka M; Kazuno Y; Takahashi N; Kawamori H; Nakamura M; Jilaihawi H; Makkar RR J Invasive Cardiol; 2018 Nov; 30(11):421-427. PubMed ID: 30373952 [TBL] [Abstract][Full Text] [Related]
51. Successful treatment of a paravalvular leak with balloon cracking and valve-in-valve TAVR. Ruge H; Erlebach M; Lieberknecht E; Lange R Catheter Cardiovasc Interv; 2020 Mar; 95(4):859-862. PubMed ID: 31794136 [TBL] [Abstract][Full Text] [Related]
52. Aortic Regurgitation after TAVR: From Bad to Worse. Hiltrop N; Adriaenssens T; Herijgers P; Dubois C J Heart Valve Dis; 2016 Mar; 25(2):182-184. PubMed ID: 27989062 [TBL] [Abstract][Full Text] [Related]
53. Numerical models of valve-in-valve implantation: effect of intentional leaflet laceration on the anchorage. Yaakobovich H; Plitman Mayo R; Zaretsky U; Finkelstein A; Marom G Biomech Model Mechanobiol; 2020 Apr; 19(2):415-426. PubMed ID: 31471756 [TBL] [Abstract][Full Text] [Related]
54. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study. Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214 [TBL] [Abstract][Full Text] [Related]
55. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve. Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659 [TBL] [Abstract][Full Text] [Related]
56. Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon-expandable prosthesis. Dhoble A; Chakravarty T; Nakamura M; Abramowitz Y; Tank R; Mihara H; Mangat G; Jilaihawi H; Shiota T; Makkar R Catheter Cardiovasc Interv; 2017 Feb; 89(3):462-468. PubMed ID: 27219874 [TBL] [Abstract][Full Text] [Related]
57. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning. Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313 [TBL] [Abstract][Full Text] [Related]
58. Early and midterm outcomes of transcatheter aortic valve replacement in patients with bicuspid aortic valves. Aalaei-Andabili SH; Beaver TM; Petersen JW; Anderson RD; Karimi A; Thoburn E; Kabir A; Bavry AA; Arnaoutakis GJ J Card Surg; 2018 Sep; 33(9):489-496. PubMed ID: 30058259 [TBL] [Abstract][Full Text] [Related]
59. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study. van Gils L; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Brecker S; Bapat V; Modine T; Soliman OI; Nersesov A; Allocco D; Falk V; Van Mieghem NM JACC Cardiovasc Interv; 2018 Jan; 11(2):119-128. PubMed ID: 29348006 [TBL] [Abstract][Full Text] [Related]
60. The feasibility of transcatheter aortic valve implantation using the Edwards SAPIEN 3 for patients with severe bicuspid aortic stenosis. Arai T; Lefèvre T; Hovasse T; Morice MC; Romano M; Benamer H; Garot P; Hayashida K; Bouvier E; Chevalier B J Cardiol; 2017 Sep; 70(3):220-224. PubMed ID: 28209261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]